NEFL and Alzheimer disease: In addition, the elevated plasma NfL levels in the high-risk group, despite the absence of changes in AD-related plasma biomarkers, suggested the potential of plasma NfL as a biomarker to detect aSyn-induced neurodegeneration in the prodromal phase of LBD.